Zhang Xing-Wang, Wang Qin, Liu Ji-Xing, Yin Xiang-Ping, Li Zhi-Yong
Key Laboratory of Animal Virology of Ministry of Agriculture, State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730046, China.
Wei Sheng Wu Xue Bao. 2006 Apr;46(2):223-6.
The gene coding for the polyprotein (PP) of foot-and-mouth disease virus (FMDV)was obtained by PCR from recombinant plasmid rpMD18-T/PP. The PCR product was digested with Xba I and Not I and inserted into the cloning site of the adenovirus shuttle vector pAdTrack-CMV, previously digested with the same enzymes. This recombinant shuttle plasmid was designated rpAd-CMV/PP. The recombinant adenovirus vector rpAd/PP was obtained by homologous recombination of plasmid rpAd-CMV/PP and adenovirus skeletal vector pAdeasy-1 in E. coli. Plasmid rpAd/PP was linearized by Pme I and transformed into 293 competent cells to pack the adenovirus using liposome mediated gene transfer method and, as a result, the recombinant adenovirus rAd/PP that contained the polyprotein coding gene was obtained. Obvious CPE could be observed under an inverted microscope, the green fluorescence protein expression can be detected under fluorescence microscope and the empty capsid of FMDV was observed under electron microscope. These results indicated that the recombinant adenovirus rAd/PP expressed the PP protein and that this protein could be assembled into the empty capsid of FMDV. The recombinant adenovirus obtained in this study can be used for further research for making FMDV recombinant adenovirus vaccine.
通过聚合酶链反应(PCR)从重组质粒rpMD18-T/PP中获得口蹄疫病毒(FMDV)多聚蛋白(PP)的编码基因。将PCR产物用XbaⅠ和NotⅠ酶切,然后插入到事先用相同酶酶切的腺病毒穿梭载体pAdTrack-CMV的克隆位点。这个重组穿梭质粒命名为rpAd-CMV/PP。重组腺病毒载体rpAd/PP是通过质粒rpAd-CMV/PP与腺病毒骨架载体pAdeasy-1在大肠杆菌中进行同源重组获得的。质粒rpAd/PP用PmeⅠ酶切线性化,然后用脂质体介导的基因转移方法转化到293感受态细胞中以包装腺病毒,结果获得了含有多聚蛋白编码基因的重组腺病毒rAd/PP。在倒置显微镜下可观察到明显的细胞病变效应(CPE),在荧光显微镜下可检测到绿色荧光蛋白表达,在电子显微镜下可观察到FMDV的空衣壳。这些结果表明重组腺病毒rAd/PP表达了PP蛋白,并且该蛋白能够组装成FMDV的空衣壳。本研究获得的重组腺病毒可用于进一步研制FMDV重组腺病毒疫苗。